Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling.

G Hausdorf, G Morf, G Beron, R Erttmann, K Winkler, G Landbeck, E W Keck

Department of Paediatric Cardiology, University Hospital, Hamburg, Federal Republic of Germany.

Cardiac performance was evaluated at least two years after doxorubicin treatment in childhood in 55 patients without overt congestive cardiomyopathy. None of the patients had received mediastinal irradiation. Computer-assisted analysis of digitised echocardiograms showed impaired rapid diastolic filling and an increased change of dimension between minimal cavity dimension and mitral valve opening. This impairment of diastolic function was related to the cumulative dose of doxorubicin. In contrast when angiotensin II was infused to increase the afterload the end systolic pressure-length and stress-shortening relation indicated normal left ventricular systolic function. But during baseline conditions the end systolic wall stress was significantly increased in patients in whom the cumulative dose of doxorubicin exceeded 360 mg/m2.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Kremer, L. C. M., van der Pal, H. J. H., Offringa, M., van Dalen, E. C., Voute, P. A. (2002). Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol 13: 819-829 [Abstract] [Full Text]  
• Gharib, M.I., Burnett, A.K. (2002). Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis. Eur J Heart Fail 4: 235-242 [Abstract] [Full Text]  
• Green, D. M., Grigoriev, Y. A., Nan, B., Takashima, J. R., Norkool, P. A., D'Angio, G. J., Breslow, N. E. (2001). Congestive Heart Failure After Treatment for Wilms' Tumor: A Report From the National Wilms' Tumor Study Group. JCO 19: 1926-1934 [Abstract] [Full Text]  
• Lipshultz, S. E., Lipsitz, S. R., Mone, S. M., Goorin, A. M., Sallan, S. E., Sanders, S. P., Orav, E. J., Gelber, R. D., Colan, S. D. (1995). Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer. NEJM 332: 1738-1744 [Abstract] [Full Text]